Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Blood

• Publication date

  2013-10-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2013-01-479972PMID 23943653PMCID PMC3798998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hsp90 Inhibitors Are Efficacious against Kaposi Sarcoma by Enhancing the Degradation of the Essential Viral Gene LANA, of the Viral Co-Receptor EphA2 as well as Other Client Proteins

  2012cited by this paper
• The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.

  2012cited by this paper
• Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers.

  2012cited by this paper
• IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway.

  2011cited by this paper
• Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

  2011cited by this paper
• Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1

  2010cited by this paper
• Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.

  2010cited by this paper
• Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab

  2010cited by this paper
• Hsp90 and co-chaperones twist the functions of diverse client proteins.

  2010cited by this paper
• Kaposi's sarcoma and its associated herpesvirus

  2010cited by this paper
• Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism

  2010cited by this paper
• A purine scaffold Hsp90 inhibitor destabilizes Bcl6 and has specific anti-tumor activity in Bcl6 dependent B-cell lymphomas

  2009cited by this paper
• FLIP-mediated autophagy regulation in cell death control

  2009cited by this paper
• Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models

  2009cited by this paper
• Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma

  2009cited by this paper
• Heat shock protein 90 is important for Sp1 stability during mitosis.

  2009cited by this paper
• Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent.

  2008cited by this paper
• Drugging the Cancer Chaperone HSP90

  2007cited by this paper
• The heat‐shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein–Barr virus‐positive NK/T‐cell lymphoma by Akt down‐regulation

  2007cited by this paper
• Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive.

  2006cited by this paper
• Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins

  2006cited by this paper
• Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.

  2006cited by this paper
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

  2006cited by this paper
• Heat shock proteins in cancer: chaperones of tumorigenesis.

  2006cited by this paper
• Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In Vivo

  2006cited by this paper
• NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo.

  2006cited by this paper
• Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.

  2004cited by this paper
• Regulation and Autoregulation of the Promoter for the Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus*

  2004cited by this paper
• KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells

  2004cited by this paper
• KSHV vFLIP binds to IKK-γ to activate IKK

  2003cited by this paper
• KSHV vFLIP binds to IKK-gamma to activate IKK.

  2003cited by this paper
• Development of purine-scaffold small molecule inhibitors of Hsp90.

  2003cited by this paper
• Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells.

  2000cited by this paper
• The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways

  2000cited by this paper
• The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.

  2000cited by this paper
• Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

  1999cited by this paper
• The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin

  1998cited by this paper
• Erratum: G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

  1998cited by this paper
• G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

  1998cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

  1995cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper
• The growth transformation of human B cells involves superinduction of hsp70 and hsp90.

  1993cited by this paper

• Inhibiting HSP27 activates the XBP1s/CerS1 interplay, which triggers DRP1-driven mitophagy, thereby protecting against cell death and promoting the KSHV lytic cycle in primary effusion lymphoma cells.

  2026cites this paper
• Therapeutic targeting of HSP90 in herpesvirus infections, past and future challenges

  2025cites this paper
• Epichaperomes: redefining chaperone biology and therapeutic strategies in complex diseases

  2025cites this paper
• Primary effusion lymphoma: therapeutic strategies targeting viral and cellular mechanisms

  2025cites this paper
• Molecular Mechanisms of Kaposi Sarcoma-Associated Herpesvirus (HHV8)-Related Lymphomagenesis

  2024cites this paper
• Modulators of the Hop-HSP90 Protein–Protein Interaction Disrupt KSHV Lytic Replication

  2024cites this paper
• Hsp70-Hsp90 organising protein (HOP/STIP1) is required for KSHV lytic replication

  2024cites this paper
• Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.

  2023cites this paper
• Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation

  2023cites this paper
• Targeting stressor-induced dysfunctions in protein-protein interaction networks via epichaperomes.

  2022cites this paper
• Bcr-Abl drives the formation of Hsp70/Bim PPI to stabilize oncogenic clients and prevent cells from undergoing apoptosis.

  2022cites this paper
• Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system

  2021cites this paper
• Small-molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in CML cells overcomes BCR-ABL-independent TKI resistance

  2021cites this paper
• Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

  2021cites this paper
• Novel Functions and Virus-Host Interactions Implicated in Pathogenesis and Replication of Human Herpesvirus 8.

  2021cites this paper
• Kaposi's Sarcoma‐associated Herpesvirus—Antiviral Treatment

  2021cites this paper
• The penalty of stress ‐ Epichaperomes negatively reshaping the brain in neurodegenerative disorders

  2021cites this paper
• Cancers associated with human gammaherpesviruses

  2021cites this paper
• Bim transfer between Bcl-2-like protein and Hsp70 underlines Bcl-2/Hsp70 crosstalk to regulate apoptosis.

  2021cites this paper
• Chaperome Networks - Redundancy and Implications for Cancer Treatment.

  2020cites this paper
• Regulation of Kaposi’s Sarcoma-Associated Herpesvirus Biology by Host Molecular Chaperones

  2020cites this paper
• Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics

  2020cites this paper
• HSF1 and Molecular Chaperones in Biology and Cancer

  2020cites this paper
• Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms.

  2019cites this paper
• Kaposi sarcoma

  2019cites this paper
• A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond.

  2019cites this paper
• Plasmablastic Lymphoma and Primary Effusion Lymphoma

  2019cites this paper
• Destabilization of ROR1 enhances activity of ibrutinib against chronic lymphocytic leukemia in vivo.

  2019cites this paper
• Signal Transduction Pathways Associated with KSHV-Related Tumors.

  2018cites this paper
• HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons

  2018cites this paper
• Chaperome heterogeneity and its implications for cancer study and treatment

  2018cites this paper
• The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity

  2018cites this paper
• Peroxisomes support human herpesvirus 8 latency by stabilizing the viral oncogenic protein vFLIP via the MAVS-TRAF complex

  2018cites this paper
• First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile

  2018cites this paper
• Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients

  2018cites this paper
• Adapting to stress — chaperome networks in cancer

  2018cites this paper
• Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma

  2018cites this paper
• Unraveling the Proteome of Endothelial Cells Latently Infected with KSHV Reveals Reliance on Peroxisome Lipid Metabolism and Redox Regulation

  2017cites this paper
• ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus–Infected Cell Autophagic Death and Represses Tumor Growth

  2017cites this paper
• Identification of a nucleoside analog active against adenosine kinase–expressing plasma cell malignancies

  2017cites this paper
• Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism

  2017cites this paper
• Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma

  2017cites this paper
• HSP90: a promising broad-spectrum antiviral drug target

  2017cites this paper
• Ganetespib, an HSP90 inhibitor, kills Epstein–Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood

  2017cites this paper
• Proteomic interrogation of HSP90 and insights for medical research

  2017cites this paper
• Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients

  2017cites this paper
• The Role of Myeloid-Derived Suppressor Cells in Viral Infection

  2017cites this paper
• Recent advances in understanding Kaposi’s sarcoma-associated herpesvirus

  2016cites this paper
• The epichaperome is an integrated chaperome network that facilitates tumour survival

  2016cites this paper
• The Hsp90 Chaperone Machinery: An Important Hub in Protein Interaction Networks.

  2016cites this paper
• Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease.

  2016cites this paper
• Targeting the ATP-dependent formation of herpesvirus ribonucleoprotein particle assembly as an antiviral approach

  2016cites this paper
• Targeting Hsp90 in Non-Cancerous Maladies.

  2016cites this paper
• Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71.

  2016cites this paper
• Emerging Roles of Extracellular Hsp90 in Cancer.

  2016cites this paper
• Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

  2016cites this paper
• Mechanisms and clinical applications of chromosomal instability in lymphoid malignancy

  2015cites this paper
• Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future

  2015cites this paper
• PU-H71: An improvement on nature's solutions to oncogenic Hsp90 addiction.

  2015cites this paper
• Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma.

  2015cites this paper
• A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species

  2015influential citation
• The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment

  2015cites this paper
• PU-H 71 : An improvement on nature ’ s solutions to oncogenic Hsp 90 addiction

  2015cites this paper
• AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation

  2015cites this paper
• Proteomics and lymphomas

  2015cites this paper
• Identification of Viral and Host Proteins That Interact with Murine Gammaherpesvirus 68 Latency-Associated Nuclear Antigen during Lytic Replication: a Role for Hsc70 in Viral Replication

  2015cites this paper
• Heat shock protein 90 controls HIV-1 reactivation from latency

  2014cites this paper
• Contribution of Viral Mimics of Cellular Genes to KSHV Infection and Disease

  2014cites this paper
• Selective targeting of the stress chaperome as a therapeutic strategy.

  2014cites this paper
• Current status of treatment for primary effusion lymphoma.

  2014cites this paper
• How do viruses trick B cells into becoming lymphomas?

  2014cites this paper
• Affinity Purification Probes of Potential Use To Investigate the Endogenous Hsp70 Interactome in Cancer

  2014cites this paper
• PI3K- and mTOR-dependent mechanisms of lapatinib resistance and resulting therapeutic opportunities

  2014cites this paper
• New approaches to treating primary effusion lymphoma

  2013cites this paper
• Naughty chaperone as a target for viral cancer.

  2013cites this paper
• Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection.

  2013cites this paper